Self-Reported Use of HIV Preexposure Prophylaxis Is Highly Accurate Among Sexual Health Clinic Patients in New York City

Sex Transm Dis. 2022 Nov 1;49(11):790-793. doi: 10.1097/OLQ.0000000000001622. Epub 2022 Mar 10.

Abstract

In New York City, 91% of sexually transmitted infection clinic patients reported preexposure prophylaxis (PrEP) use that matched the detection of PrEP in their serum. Self-report had 80% sensitivity and 96% specificity ( κ = 0.79) compared with measured PrEP. Our findings suggest that self-report may be a valid indicator of PrEP uptake.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Homosexuality, Male
  • Humans
  • Male
  • New York City / epidemiology
  • Pre-Exposure Prophylaxis*
  • Self Report
  • Sexual Health*

Substances

  • Anti-HIV Agents